|The following article features coverage from the 2021 ASCO Quality Care Symposium. Click here to read more of Oncology Nurse Advisor‘s conference coverage.|
A mobile health tool for monitoring symptoms of cancer treatment toxicity was found to be feasible and allow for rapid clinician response. These findings were presented during the 2021 ASCO Quality Care Symposium.
Treatment toxicity after chemotherapy is common among patients with lymphoma, occurring in up to 98.3%. Although patients are educated about toxicity prior to treatment, the large amount of information can be overwhelming to some, leading to gaps in care.
Researchers from University of Arizona College of Science developed a web-based mobile application to address gaps in care and monitor patient symptoms. The platform introduces chemotherapy toxicity and surveys patients on their symptoms. Providers are able to access a summary and track their patient’s status. Patients exhibiting problematic symptoms are flagged, prompting the clinician to follow-up with the patient.
A total of 310 patients were enrolled in this trial as of January 2021. Patients were median age 64 years and 49% were women.
A total of 8916 patient check-ins were prompted and 2963 responses occurred (33.23%). A total of 531 responses from 109 patients were flagged for follow-up. Common symptoms included fatigue; nausea, vomiting, or diarrhea; abdominal pain; cough or dyspnea; and numbness or tingling.
Flagged responses (60%) were followed-up within the same day, 84% were followed-up within 4 hours of symptom report.
Almost three-quarters of patients (72%) indicated they were satisfied with the tool, rating their experience as 4 or higher on a scale of 1 to 5 (5 being the most favorable).
This study found that electronically capturing patient-reported symptoms of treatment toxicity was feasible and allowed for prompt follow-up.
Disclosure: Some authors declared affiliation with biotech, pharmaceutical, and/or device companies. Please see the original reference for the full list of authors’ disclosures.
Read more of Oncology Nurse Advisor’s coverage of the 2021 ASCO Quality Care Symposium by visiting the conference page.
Sanyal A, Mistretta S, Fulton M, Janssen CW. Mobile-health tool for timely management of cancer treatment toxicity. J Clin Oncol. 2021;39(suppl 28):abstr 321. doi:10.1200/JCO.2020.39.28_suppl.321